The Discounted Cash Flow (DCF) valuation of Mirum Pharmaceuticals Inc (MIRM) is (56.41) USD. With the latest stock price at 53.28 USD, the upside of Mirum Pharmaceuticals Inc based on DCF is -205.9%.
Based on the latest price of 53.28 USD and our DCF valuation, Mirum Pharmaceuticals Inc (MIRM) is a sell. selling MIRM stocks now will result in a potential gain of 205.9%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.2% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (207.01) - (35.25) | (56.41) |
| Upside | -488.5% - -166.2% | -205.9% |